All Stories

  1. Risk Factors of COVID-19 Severity and Related Death in Children in the Post-Pandemic Era
  2. Reno-ocular syndromes: pathophysiological mechanisms linking kidney and ocular disorders
  3. Point‐of‐Care Ultrasound for Pediatric Urethral Catheterization: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
  4. COVID-19 Vaccine Effectiveness in Individuals with Alcohol and Tobacco Use Disorders: A Propensity Score-Matched Study Using Nationwide Brazilian Data
  5. Efficacy, safety, and biomarker changes of B-cell activating factor and A proliferation-inducing ligand-targeted therapies in IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials
  6. Effectiveness of COVID-19 Vaccine Boosters in Children Across Pandemic and Endemic Periods
  7. Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective Variant
  8. Response to the Letter to the Editor re Maternal and perinatal risk factors of hypospadias: a case-control study
  9. Urinary angiotensin II and angiotensin-(1–7) in gestational hypertension and preeclampsia subtypes: clinical and biochemical correlations
  10. MOG Antibody Disease (MOGAD) Presenting as Acute Disseminated Encephalomyelitis (ADEM): Insights from Cerebrospinal Fluid Cytokine Profiling
  11. Effectiveness of COVID-19 Vaccines Against Hospitalization and Severe Disease in Children with Diabetes Mellitus During Pandemic and Post-Pandemic Eras
  12. Maternal and perinatal risk factors of hypospadias: a case-control study
  13. Pierson Syndrome: An Update
  14. APOL1 kidney risk variants and outcomes in children with congenital anomalies of the kidney and urinary tract
  15. Identification and Characterization of Alamandine-(1-5), a New Component of the Renin-Angiotensin System
  16. Kangaroo Mother Care and skin-to-skin contact can impact maternal postpartum depression: a narrative review
  17. O Método Canguru e o contato pele a pele podem impactar a depressão pós-parto materna: uma revisão narrativa
  18. Effectiveness of oseltamivir in hospitalised obstetric patients with COVID-19: a retrospective cohort study using a Brazilian national database
  19. Response to Commentary on “Risk factors for perinatal and neonatal mortality in cases with congenital anomalies of the kidney and urinary tract: a nested cohort study”
  20. Dynamic ultrasound evaluation of morphological and functional urinary tract characteristics in newborns and young infants with myelomeningocele
  21. Prune-belly Syndrome: An Update
  22. Psycho-neuroendocrine-immune interpretation of schizophrenia pathogenesis and treatment
  23. Risk factors for perinatal and neonatal mortality in cases with congenital anomalies of the kidney and urinary tract: a nested cohort study
  24. Comparative performance of twelve machine learning models in predicting COVID-19 mortality risk in children: a population-based retrospective cohort study in Brazil
  25. Risk factors for early mortality in infants with congenital anomalies of the kidney and urinary tract: a nested cohort study
  26. The Role of Renin-Angiotensin System in Diabetic Nephropathy: An Update
  27. COVID-19 Vaccine Effectiveness and Risk Factors of Booster Failure in 480,000 Patients with Diabetes Mellitus: A Population-Based Cohort Study
  28. Efficacy of a Neuroimmune Therapy Including Pineal Methoxyindoles, Angiotensin 1-7, and Endocannabinoids in Cancer, Autoimmune, and Neurodegenerative Diseases
  29. Neuroinflammation in kidney disease and dialysis
  30. Dental anomalies in a patient with Tyrosinemia type I: first case report in the literature
  31. Oxidative Stress in Renal Health
  32. Cytokine Profiles Associated With Clinical Outcomes in Pediatric Patients With Meningitis: A Systematic Review and Meta-Analysis
  33. Efficacy, safety, and biomarker changes of B-cell activating factor- and A proliferation-inducing ligand-targeted therapies in IgA nephropathy: A systematic review and meta-analysis of randomized controlled trials
  34. Expression of immunophenotypic markers in blood mononuclear cells of patients with advanced head and neck squamous cells carcinoma
  35. Inflammatory markers in cerebrospinal fluid in pediatric Brazilian spotted fever with neurological manifestations
  36. Strength Training can Modulate Urinary Adipokine Levels in Healthy Young Males
  37. Involvement of Renin-Angiotensin system (RAS) components in mild traumatic brain injury
  38. Vaccine protection against COVID-19-related death in patients with schizophrenia: A retrospective cohort study
  39. Kidney transplantation reduces biomarkers of endothelial dysfunction
  40. Potential Role of Bone Metabolism Markers in Kidney Transplant Recipients
  41. A case of suicide secondary to diethylene glycol intentional ingestion
  42. Urinary L-FABP as an Early Biomarker for Pediatric Acute Kidney Injury Following Cardiac Surgery with Cardiopulmonary Bypass: A Systematic Review and Meta-Analysis
  43. Urinary L-FABP as an Early Biomarker for Pediatric Acute Kidney Injury Following Cardiac Surgery with Cardiopulmonary Bypass: A Systematic Review and Meta-analysis
  44. Effectiveness of oseltamivir in reducing COVID-19-related in-hospital deaths: A pharmacoepidemiological study
  45. Translation, cross-cultural adaptation and validation of the Short Screening Instrument for Psychological Problems in Enuresis for use in Brazil (SSIPPE-Br)
  46. Potential Role of Novel Cardiovascular Biomarkers in Pediatric Patients with Chronic Kidney Disease
  47. Predictive models of chronic kidney disease progression in pediatric patients
  48. Potential urinary biomarkers in preeclampsia: a narrative review
  49. Natural history of albuminuria in a large cohort of children and adolescents with sickle cell anemia from Brazil
  50. Efficacy and Safety of SGLT2 Inhibitors in Pediatric Patients and Young Adults: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
  51. Safety and efficacy of sotagliflozin in patients with type II diabetes mellitus and chronic kidney disease: a meta-analysis of randomized controlled trials
  52. The View of Pediatric Nephrotic Syndrome as a Podocytopathy
  53. Doença renal crônica pediátrica: índices de contagem de células sanguíneas como marcadores de inflamação
  54. Pediatric chronic kidney disease: blood cell count indexes as inflammation markers
  55. Multiple odontogenic keratocysts in a patient with Lowe syndrome: a first case report and literature review
  56. Association of Prior COVID-19 Vaccination With SARS-CoV-2 Infection and Death in Children and Young Persons During the Omicron Variant Period in Brazil
  57. Bartter-like Syndrome Induced By Tacrolimus in a Renal Transplanted Boy: A Case Report
  58. The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review
  59. Acute and Chronic Effects of Strength Training on Plasma Levels of Adipokines in Man
  60. How the COVID-19 pandemic has affected children and adolescents’ sleep habits: a systematic review
  61. Nephrotic Syndrome and Renin-angiotensin System: Pathophysiological Role and Therapeutic Potential
  62. Safety and efficacy of new potassium binders on hyperkalemia management in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials
  63. Use of C-reactive protein to guide the antibiotic therapy in hospitalized patients: a systematic review and meta-analysis
  64. Multi-population genome-wide association study implicates immune and non-immune factors in pediatric steroid-sensitive nephrotic syndrome
  65. Renal toxicity caused by diethylene glycol: an overview
  66. Redox Signaling in Chronic Kidney Disease-Associated Cachexia
  67. Maternal risk factors for congenital anomalies of the kidney and urinary tract: A case-control study
  68. Novel Biomarkers for Posterior Urethral Valve
  69. Effectiveness of BNT162b2 and CoronaVac vaccines against omicron in children aged 5 to 11 years
  70. Estimated glomerular filtration rate in Brazilian adults with sickle cell disease: results from the REDS-III multicenter cohort study
  71. Imaging Markers of Neurologic Damage in COVID-19: A Systematic Review
  72. The challenges of chemotherapy adjustment in obese individuals
  73. The use and role of telemedicine in maternal fetal medicine around the world: an up-to-date
  74. Inherited Fanconi syndrome
  75. Validation of the Vancouver Symptom Score Questionnaire for bladder and bowel dysfunction for Brazilian children and adolescents
  76. Vaccine Effectiveness against SARS-CoV-2 Variants in Adolescents from 15 to 90 Days after Second Dose: A Population-Based Test-Negative Case-Control Study
  77. Cardiovascular and renal effects of SGLT2 inhibitor initiation in acute heart failure: a meta-analysis of randomized controlled trials
  78. Machine Learning Algorithms to Predict Outcomes in Children and Adolescents with Covid-19: A Systematic Review
  79. Congenital Solitary Functioning Kidney: A Review
  80. Risk for Severe Illness and Death among Pediatric Patients with Down Syndrome Hospitalized for COVID-19, Brazil
  81. Immuno-oncology in head and neck squamous cell carcinoma - a narrative review
  82. Nut-enriched energy restricted diet has potential to decrease hunger in women at cardiometabolic risk: a randomized controlled trial (Brazilian Nuts Study)
  83. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy in pediatric patients: a meta-analysis
  84. Pharmacogenomic markers of glucocorticoid response in congenital adrenal hyperplasia
  85. Relationship between primary monosymptomatic enuresis and process toilet training: a case-control
  86. Costus spiralis extract restores kidney function in cisplatin-induced nephrotoxicity model: Ethnopharmacological use, chemical and toxicological investigation
  87. Modified Levels of Renin Angiotensin Related Components in the Frontal Cortex and Hippocampus were Associated with Neuroinflammation and Lower Neuroprotective Effects of NGF During Acute Hepatic Encephalopathy in Mice
  88. Clinical Outcomes of Omicron Variant (B.1.1.529) Infection in Children and Adolescents Hospitalized With COVID-19 in Brazil With Observational Data on the Efficacy of the Vaccines in Adolescents
  89. The association between pre‐existing asthma and reduced risk of death among children and adolescents hospitalized with COVID‐19 in Brazil
  90. Evaluation of circulating renin-angiotensin system components in pediatric patients with acute leukemia: a pilot study
  91. Idiopathic Nephrotic Syndrome in Pediatrics: An Up-to-date
  92. Evaluation of novel bone metabolism markers in kidney transplant recipients
  93. Relationship between toilet training process and primary nocturnal enuresis in children and adolescents – A systematic review
  94. Evaluation of circulating renin-angiotensin system components in pediatric patients with acute leukemia: a pilot study
  95. Renal Toxicity Caused by Diethylene Glycol: an Overview
  96. Multi-population genome-wide association study implicates both immune and non-immune factors in the etiology of pediatric steroid sensitive nephrotic syndrome
  97. Hemostasis and oxidative stress in chronic kidney disease in children and adolescents
  98. Acute Post-Streptococcal Glomerulonephritis in Children: A Comprehensive Review
  99. Use of C-reactive protein to guide antibiotic therapy in hospitalized patients: a systematic review and meta-analysis
  100. Chronic Kidney Disease-Mineral Bone Disease Biomarkers in Kidney Transplant Patients
  101. Clinical Impact and Risk Factors of Mortality in Hospitalized Children and Adolescents With Hematologic Diseases and COVID-19: An Observational Retrospective Cohort Study
  102. Better healthcare can reduce the risk of COVID-19 in-hospital post-partum maternal death: evidence from Brazil
  103. Risk factors for acute kidney injury after liver transplantation in intensive care unit: a retrospective cohort study
  104. Interactions between the intrarenal dopaminergic and the renin–angiotensin systems in the control of systemic arterial pressure
  105. Are in‐hospital COVID‐19‐related mortality and morbidity in pregnancy associated with gestational age?
  106. The treatment of atypical hemolytic uremic syndrome with eculizumab in pediatric patients: a systematic review
  107. Renin-Angiotensin System in Huntington′s Disease: Evidence from Animal Models and Human Patients
  108. The Need to Study Clinical Outcomes in Children and Adolescents With COVID-19 From Middle- and Low-Income Regions
  109. Nephrogenesis, Renal Function, and Biomarkers in Preterm Newborns
  110. Non-surgical management of vesicoureteral junction obstruction: a case report
  111. Tubular and glomerular biomarkers of renal tissue function in the urine of fetuses with posterior urethral valves
  112. Renin-angiotensin system in normal pregnancy and in preeclampsia: A comprehensive review
  113. Potential Role of Adult Hippocampal Neurogenesis in Traumatic Brain Injury
  114. Involvement of the Renin-Angiotensin System in Stress: State of the Art and Research Perspectives
  115. The Impact of Vaccination Worldwide on SARS-CoV-2 Infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants
  116. Comparison of the First and Second Waves of the Coronavirus Disease 2019 Pandemic in Children and Adolescents in a Middle-Income Country: Clinical Impact Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Gamma Lineage
  117. Outcomes and risk factors for death among hospitalized children and adolescents with kidney diseases and COVID-19: an analysis of a nationwide database
  118. Outcomes and risk factors of death among hospitalized children and adolescents with obesity and COVID ‐19 in Brazil: An analysis of a nationwide database
  119. The Curcumin Supplementation with Piperine Can Influence the Acute Elevation of Exercise-Induced Cytokines: Double-Blind Crossover Study
  120. Risk factors for COVID ‐19‐related mortality in hospitalized children and adolescents with diabetes mellitus: An observational retrospective cohort study
  121. Renin angiotensin system molecules and chemokine (C-C motif) ligand 2 (CCL2) in chronic kidney disease patients
  122. Evaluation of insertion/deletion (I/D) polymorphisms of ACE gene and circulating levels of angiotensin II in congenital anomalies of the kidney and urinary tract
  123. Nephrogenic diabetes insipidus: a comprehensive overview
  124. The potential role of renin-angiotensin system in mild traumatic brain injury
  125. Global scientific production in the pre-Covid-19 Era: An analysis of 53 countries for 22 years
  126. Costus Spiralis Extract Restores Kidney Function in Cisplatin-Induced Nephrotoxicity Model: Ethnopharmacological Use, Chemical and Toxicological Investigation
  127. Acute kidney injury in pediatrics: an overview focusing on pathophysiology
  128. Renal Involvement in Pediatric Patients with COVID-19: An Up-to-date Review
  129. Immunoglobulin A nephropathy in paediatrics: An up‐to‐date
  130. Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children
  131. Risk factors for COVID-19 mortality in hospitalised children and adolescents in Brazil – Authors' reply
  132. Glucocorticoid receptor Gene (NR3C1) Polymorphisms and Haplotypes in patients with congenital adrenal hyperplasia
  133. Evaluation of Urinary Tract Dilation Classification System for Prediction of Long-Term Outcomes in Isolated Antenatal Hydronephrosis: A Cohort Study
  134. Novel Biomarkers for Lupus Nephritis in the “OMICS” Era
  135. Renin-Angiotensin System in Central Nervous System Diseases and its Interaction with COVID-19
  136. Alport Syndrome: A Comprehensive Review on Genetics, Pathophysiology, Histology, Clinical and Therapeutic Perspectives
  137. An analysis of chronic kidney disease as a prognostic factor in pediatric cases of COVID-19
  138. Biomarkers of renal function in preterm neonates at 72 h and 3 weeks of life
  139. Postnatal urinary tract dilatation classification: improvement of the accuracy in predicting kidney injury
  140. The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis
  141. Renin Angiotensin System (RAS) and Immune System Profile in Specific Subgroups with COVID-19
  142. Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database
  143. Editorial: The Role of the Renin-Angiotensin System in the Central Nervous System
  144. The usefulness of copeptin for the diagnosis of nephrogenic diabetes insipidus in infancy: a case report
  145. Novel Kidney Injury Biomarkers in A Large Cohort of Children with Sickle Cell Anemia
  146. Traumatic brain injury biomarkers in pediatric patients: a systematic review
  147. Lower limb strength training (LLST) modulates serum and urinary levels of renin angiotensin system molecules in healthy young males
  148. Telomere Shortening and Psychiatric Disorders: A Systematic Review
  149. Attention deficit and hyperactivity disorder and nocturnal enuresis co-occurrence in the pediatric population: a systematic review and meta-analysis
  150. Evaluation of Insertion/deletion (I/D) Polymorphisms of ACE Gene in Congenital Anomalies of The Kidney and Urinary Tract From a Brazilian Pediatric Population
  151. Renovascular hypertension in pediatric patients: update on diagnosis and management
  152. Circulating Angiotensin-(1–7) Is Reduced in Alzheimer’s Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study
  153. Factors Associated with Primary Hypertension in Pediatric Patients: An Up-to-Date
  154. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
  155. Copy Number Variant Analysis and Genome-wide Association Study Identify Loci with Large Effect for Vesicoureteral Reflux
  156. Attention Deficit and Hyperactivity Disorder and Enuresis co-occurrence in the pediatric population: a systematic review and meta-analysis
  157. COVID-19 pandemic and the answer of science: a year in review
  158. COVID-19 and Renal Diseases: An Update
  159. ACE2 activator diminazene aceturate exerts renoprotective effects in gentamicin-induced acute renal injury in rats
  160. How is COVID-19 pandemic impacting mental health of children and adolescents?
  161. COVID-19 related coagulopathy: what is known up to now
  162. Emotional, Behavioral, and Psychological Impact of the COVID-19 Pandemic
  163. Hepatorenal syndrome in children: a review
  164. Corrigendum to “Two protocols of aerobic exercise modulate the counter-regulatory axis of the renin-angiotensin system” [Heliyon 6 (1) (January 2020) e03208]
  165. 2020 update on the renin–angiotensin–aldosterone system in pediatric kidney disease and its interactions with coronavirus
  166. Immune-Based Therapies for Traumatic Brain Injury: Insights from Pre-Clinical Studies
  167. Angiotensin-converting enzyme 2, the SARS-CoV-2 cellular receptor, is widely expressed in human myometrium and uterine leiomyoma
  168. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System
  169. Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations
  170. Acute kidney injury biomarkers in the critically ill
  171. TNF, IL-6, and IL-10 cytokines levels and their polymorphisms in renal function and time after transplantation
  172. Análise da força de preensão palmar, sensibilidade cutânea manual e uso funcional das mãos em crianças e adolescentes com doença renal crônica em hemodiálise
  173. ACE2/Angiotensin-(1-7)/Mas Receptor Axis in Human Cancer: Potential Role for Pediatric Tumors
  174. Editorial: Developmental Disorders of the Kidney and Urinary Tract: Recent Insights From Clinical and Molecular Studies
  175. Coronavirus Disease Pandemic Is a Real Challenge for Brazil
  176. Covid-19: the renin–angiotensin system imbalance hypothesis
  177. Bartter’s syndrome: clinical findings, genetic causes and therapeutic approach
  178. Biomarkers in vesicoureteral reflux: an overview
  179. Is SARS-CoV-2 Vertically Transmitted?
  180. Renin–angiotensin system molecules are associated with subclinical atherosclerosis and disease activity in rheumatoid arthritis
  181. Urinary tract infection in pediatrics: an overview
  182. Prevalence and risk factors for albuminuria and glomerular hyperfiltration in a large cohort of children with sickle cell anemia
  183. The Renin Angiotensin System and Bipolar Disorder: A Systematic Review
  184. Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade
  185. Association between dyslipidemia and CCL2 in patients undergoing hemodialysis
  186. Evidence for interactions between inflammatory markers and renin-angiotensin system molecules in the occurrence of albuminuria in children with sickle cell anemia
  187. Science funding crisis in Brazil and COVID-19: deleterious impact on scientific output
  188. Two protocols of aerobic exercise modulate the counter-regulatory axis of the renin-angiotensin system
  189. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
  190. Renin-angiotensin system and Alzheimer’s disease pathophysiology: From the potential interactions to therapeutic perspectives
  191. The Renin-Angiotensin System and the Cerebrovascular Diseases: Experimental and Clinical Evidence
  192. Inflammatory biomarkers in children with cerebral palsy: A systematic review
  193. Renin angiotensin system molecules and nitric oxide local interactions in the adrenal gland of Trypanosoma cruzi infected rats
  194. Potential Role of Nutrient Intake and Malnutrition as Predictors of Uremic Oxidative Toxicity in Patients with End-Stage Renal Disease
  195. Anti-inflammatory effects of C-peptide on kidney of type 1 diabetes mellitus animal model
  196. Urinary tract infection in pediatrics: an overview
  197. Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study
  198. Cell‐Derived Microparticles and Von Willebrand Factor in Brazilian Renal Transplant Recipients
  199. A clinical predictive model of renal injury in children with isolated antenatal hydronephrosis
  200. Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients
  201. Beneficial Effects of the Angiotensin-Converting Enzyme 2 Activator Dize in Renovascular Hypertension
  202. Profile and scientific output of researchers recipients of CNPq productivity grant in the field of medicine
  203. Distal renal tubular acidosis: genetic causes and management
  204. The protective arm of the renin‐angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves
  205. A Predictive Model of Postnatal Surgical Intervention in Children With Prenatally Detected Congenital Anomalies of the Kidney and Urinary Tract
  206. Pediatric Patients With Steroid-Sensitive Nephrotic Syndrome Have Higher Expression of T Regulatory Lymphocytes in Comparison to Steroid-Resistant Disease
  207. Interactions between local Renin Angiotensin System and nitric oxide in the brain of Trypanosoma cruzi infected rats
  208. Author Correction: The copy number variation landscape of congenital anomalies of the kidney and urinary tract
  209. Hepatic encephalopathy: Lessons from preclinical studies
  210. Effect of blockade of nitric oxide in heart tissue levels of Renin Angiotensin System components in acute experimental Chagas disease
  211. Brazil's endangered postgraduate system
  212. The copy number variation landscape of congenital anomalies of the kidney and urinary tract
  213. Evidence for a role of Angiotensin Converting Enzyme 2 in proteinuria of idiopathic nephrotic syndrome
  214. First report of collapsing variant of focal segmental glomerulosclerosis triggered by arbovirus: dengue and Zika virus infection
  215. Pediatric lupus nephritis
  216. Posterior urethral valves: comparison of clinical outcomes between postnatal and antenatal cohorts
  217. Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease
  218. Neurotrophic Factors in Parkinson’s Disease: What Have we Learned from Pre-Clinical and Clinical Studies?
  219. A clinical predictive model of renal injury in children with congenital solitary functioning kidney
  220. A clinical predictive model of chronic kidney disease in children with posterior urethral valves
  221. RAS in the Central Nervous System: Potential Role in Neuropsychiatric Disorders
  222. Glomerular hyperfiltration and β-2 microglobulin as biomarkers of incipient renal dysfunction in cancer survivors
  223. Dental Alterations in Renal Tubular Acidosis: Case Reports
  224. Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer’s Disease
  225. Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia
  226. Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia
  227. SAT0118 Association of renin-angiotensin system imbalance with subclinical atherosclerosis and disease activity in rheumatoid arthritis
  228. THU0080 Serum irisin and myostatin levels in patients with rheumatoid arthritis
  229. Plasma and cerebrospinal fluid levels of cytokines as disease markers of neurologic manifestation in long-term HTLV-1 infected individuals
  230. Inflammatory molecules and neurotrophic factors as biomarkers of neuropsychomotor development in preterm neonates: A Systematic Review
  231. The protective arm of the renin–angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves
  232. Autoimmune Hepatitis and Autoimmune Hepatitis Overlap With Sclerosing Cholangitis
  233. Serum levels of angiotensin converting enzyme as a biomarker of liver fibrosis
  234. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System
  235. Renin Angiotensin System and Cytokines in Chronic Kidney Disease: Clinical and Experimental Evidence
  236. T-lymphocyte-expressing inflammatory cytokines underlie persistence of proteinuria in children with idiopathic nephrotic syndrome
  237. Immune status of patients with haemophilia A before exposure to factor VIII: first results from the HEMFIL study
  238. The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research
  239. Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis?
  240. Single Nucleotide Variants in A Family of Monozygotic Twins Discordant for the Phenotype Congenital Megaureter: A Genomic Analysis
  241. Kidney–brain axis inflammatory cross-talk: from bench to bedside
  242. Erratum to: mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy
  243. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy
  244. Posterior urethral valve in fetuses: evidence for the role of inflammatory molecules
  245. Bj-PRO-5a and Bj-PRO 10c Found at C-Type Natriuretic Peptide Precursor of Bothrops jararaca Change Renal Function of Hypertensive Rats
  246. Urinary Levels of IL-1β and GDNF in Preterm Neonates as Potential Biomarkers of Motor Development: A Prospective Study
  247. A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates
  248. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy
  249. Cytokine Signature in End-Stage Renal Disease Patients on Hemodialysis
  250. Renin angiotensin system in liver diseases: Friend or foe?
  251. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients
  252. Early changes in adipokines from overweight to obesity in children and adolescents
  253. Characterization of an experimental model of progressive renal disease in rats
  254. Peripheral levels of angiotensins are associated with depressive symptoms in Parkinson's disease
  255. Early changes in adipokines from overweight to obesity in children and adolescents
  256. Zika virus challenges for neuropsychiatry
  257. Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome
  258. Immunoglobulin A nephropathy: a pathophysiology view
  259. Immune markers in the RASopathy neurofibromatosis type 1
  260. ACE inhibition, ACE2 and angiotensin-(1–7) axis in kidney and cardiac inflammation and fibrosis
  261. Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients
  262. Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis
  263. Frequência de sobrepeso e obesidade em crianças e adolescentes com autismo e transtorno do déficit de atenção/hiperatividade
  264. Nutritional evaluation of children with chronic cholestatic disease
  265. Nutritional evaluation of children with chronic cholestatic disease
  266. The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood
  267. Chemokines as Potential Markers in Pediatric Renal Diseases
  268. Uromodulin: a new biomarker of fetal renal function?
  269. Update on the approach of urinary tract infection in childhood
  270. Whole-exome sequencing as a diagnostic tool for distal renal tubular acidosis
  271. Update on the approach of urinary tract infection in childhood
  272. Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case report
  273. Propriedades psicométricas da Escala de Responsividade Social-2 para Transtornos do Espectro Autista
  274. Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease
  275. Dental findings in Brazilian patients with Fanconi syndrome
  276. A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome
  277. The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update
  278. Anthropometric and Biochemical Profile of Children and Adolescents with Chronic Kidney Disease in a Predialysis Pediatric Interdisciplinary Program
  279. Hemostatic Parameters according to Renal Function and Time after Transplantation in Brazilian Renal Transplanted Patients
  280. Increased Migratory and Activation Cell Markers of Peripheral Blood Lymphocytes in an Experimental Model of Nephrotic Syndrome
  281. Plasma levels of alarmin IL-33 are unchanged in autism spectrum disorder: A preliminary study
  282. Mas in the Kidney
  283. Chemokines as Potential Markers in Pediatric Renal Diseases
  284. Mas and Inflammation
  285. Profile and scientific production of the Brazilian Council for Scientific and Technological Development (CNPq) researchers in the field of Hematology/Oncology
  286. Congenital anomalies of the kidney and urinary tract: An embryogenetic review
  287. Angiotensin type 2 receptor gene are associated with ureteropelvic junction obstruction
  288. A predictive model of chronic kidney disease in patients with congenital anomalies of the kidney and urinary tract
  289. PAX2 Polymorphisms and Congenital Abnormalities of the Kidney and Urinary Tract in a Brazilian Pediatric Population: Evidence for a Role in Vesicoureteral Reflux
  290. The Therapeutic Role of Renin-Angiotensin System Blockers in Obesity- Related Renal Disorders
  291. Dental Manifestations in Two Patients With Bartter’s Syndrome
  292. Progression of CKD in children
  293. Chemokines as Potential Markers in Pediatric Renal Diseases
  294. Study of the association between the BMP4 gene and congenital anomalies of the kidney and urinary tract
  295. Cognitive alterations in chronic kidney disease: an update
  296. Neuropsychiatric disorders and renal diseases: an update
  297. Action of a pancreatin and an Aspergillus oryzae protease on whey proteins: correlation among the methods of analysis of the enzymatic hydrolysates
  298. The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies
  299. Profile and scientific production of Brazilian National Council of Technological and Scientific Development researchers in Pediatrics
  300. Diagnostic Accuracy of Renal Pelvic Dilatation for Detecting Surgically Managed Ureteropelvic Junction Obstruction
  301. Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis
  302. Use of Different Proteases to Obtain Whey Protein Concentrate Hydrolysates with Inhibitory Activity toward Angiotensin-Converting Enzyme
  303. Beneficial Effects of the Activation of the Angiotensin-(1–7) Mas Receptor in a Murine Model of Adriamycin-Induced Nephropathy
  304. Enzymatic hydrolysis of whey protein concentrate: effect of enzyme type and enzyme:substrate ratio on peptide profile
  305. ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
  306. Is there a correlation between journal impact factor and researchers’ performance? A study comprising the fields of clinical nephrology and neurosciences
  307. Assessing pre-clinical ventricular dysfunction in obese children and adolescents: the value of speckle tracking imaging
  308. Autoimmune hepatitis in childhood: The role of genetic and immune factors
  309. Correlation between the Degree of Hydrolysis and the Peptide Profile of Whey Protein Concentrate Hydrolysates: Effect of the Enzyme Type and Reaction Time
  310. Interactions between Cytokines, Congenital Anomalies of Kidney and Urinary Tract and Chronic Kidney Disease
  311. Perfil e análise da produção científica dos pesquisadores brasileiros em Neurociência Clínica
  312. Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases
  313. Máscara laríngea ProSealTM como via de administração de surfactante no tratamento da síndrome do desconforto respiratório em recém-nascido pré-termo
  314. Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study
  315. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis
  316. Early risk factors for neonatal mortality in CAKUT: analysis of 524 affected newborns
  317. Aplicação da biologia molecular na abordagem da síndrome de Bartter: relato de caso
  318. ADAMTS13 and Von Willebrand factor in patients undergoing hemodialysis
  319. Clinical Course of 822 Children with Prenatally Detected Nephrouropathies
  320. Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria
  321. Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
  322. Current knowledge on esophageal atresia
  323. Diagnostic criteria for autoimmune hepatitis in children: A challenge for pediatric hepatologists
  324. Imaging for evaluation of urologic abnormalities in infants with fetal hydronephrosis: advances and controversies
  325. Newer Doppler echocardiography techniques in assessment of heart function in obese patients
  326. Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury
  327. Typical Features of Amelogenesis Imperfecta in Two Patients with Bartter’s Syndrome
  328. ADAMTS13 and Von Willebrand factor assessment before and after kidney transplantation
  329. The renin–angiotensin–aldosterone system in 2011: role in hypertension and chronic kidney disease
  330. Comparison of Brazilian researchers in clinical medicine: are criteria for ranking well-adjusted?
  331. Inflamação na doença renal crônica: papel de citocinas
  332. Pesquisadores do Conselho Nacional de Desenvolvimento Científico e Tecnológico na área de Cardiologia
  333. Características clínicas e laboratoriais associadas à nefroangioesclerose hipertensiva confi rmada por biópsia renal
  334. Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods
  335. Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies
  336. Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups
  337. Angiotensin-converting enzyme inhibition changes the metabolic response to neuroglucopenic stress
  338. Bone disease and cytokines in idiopathic hypercalciuria: a review
  339. Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity
  340. Combined Use of Late Phase Dimercapto-Succinic Acid Renal Scintigraphy and Ultrasound as First Line Screening After Urinary Tract Infection in Children
  341. Primary versus secondary hypertension in children followed up at an outpatient tertiary unit
  342. Behavioral disorders and low quality of life in children and adolescents with chronic kidney disease
  343. Anti-Inflammatory Effects of the Activation of the Angiotensin-(1-7) Receptor, Mas, in Experimental Models of Arthritis
  344. ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats
  345. Is remifentanil an option for premedication for neonatal endotracheal intubation?
  346. Hemostatic changes in patients with end stage renal disease undergoing hemodialysis
  347. Risk Factors for Recurrent Urinary Tract Infections in a Cohort of Patients With Primary Vesicoureteral Reflux
  348. Risk Factors for Early Onset of Diabetic Nephropathy in Pediatric Type 1 Diabetes
  349. Citocinas e quimiocinas no transplante renal
  350. Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice
  351. Genetic deletion of the angiotensin-(1–7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria
  352. Molecular Pathophysiology of Renal Tubular Acidosis
  353. Independent risk factors for renal damage in a series of primary vesicoureteral reflux: A multivariate analysis
  354. Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis
  355. Renin-angiotensin system in the pathogenesis of liver fibrosis
  356. Immune Mediators in Idiopathic Nephrotic Syndrome: Evidence for a Relation Between Interleukin 8 and Proteinuria
  357. Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme
  358. The renin–angiotensin system and diabetes: An update
  359. Clinical outcome of children with chronic kidney disease in a pre-dialysis interdisciplinary program
  360. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
  361. Development of hepatorenal syndrome in bile duct ligated rats
  362. Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients
  363. Early awakening and extubation with remifentanil in ventilated premature neonates
  364. Sedação e analgesia em neonatologia
  365. Avaliação da dor em neonatologia
  366. The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetes
  367. The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1–7)
  368. Morphine versus remifentanil for intubating preterm neonates
  369. Risk of hypertension in primary vesicoureteral reflux
  370. Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-(1–7) in End-Stage Renal Disease
  371. Renal function in transgenic rats expressing an angiotensin-(1–7)-producing fusion protein
  372. Pathophysiology of Arterial Hypertension: Insights from Pediatric Studies
  373. Predictive factors of chronic kidney disease in severe vesicoureteral reflux
  374. The Therapeutic Potential of Angiotensin-(1-7) as a Novel Renin- Angiotensin System Mediator
  375. Remifentanil for sedation and analgesia in a preterm neonate with respiratory distress syndrome
  376. Successful management of concomitant omphalocele, accessory hepatic lobe, and biliary atresia in a 44-day-old boy
  377. Nonpeptide AVE 0991 Is an Angiotensin-(1-7) Receptor Mas Agonist in the Mouse Kidney
  378. New method of surgical delayed closure of giant omphaloceles: Lazaro da Silva’s technique
  379. The renin angiotensin system in childhood hypertension: Selective increase of angiotensin-(1-7) in essential hypertension
  380. Angiotensin-(1–7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors
  381. Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
  382. Characterization of a New Selective Antagonist for Angiotensin-(1-7), D-Pro7-Angiotensin-(1-7)
  383. Spontaneous improvement of hypertension in multicystic dysplastic kidney: a case report
  384. Interactions Between Angiotensin-(1-7), Kinins, and Angiotensin II in Kidney and Blood Vessels
  385. VISCERAL LARVA MIGRANS AND TROPICAL PYOMYOSITIS: A CASE REPORT
  386. Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1-7) in water-loaded rats
  387. Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1–7) antagonist in normotensive and hypertensive rats
  388. Renal actions of angiotensin-(1-7)
  389. Evidence for a Physiological Role of Angiotensin-(1-7) in the Control of Hydroelectrolyte Balance
  390. Characterization of a new angiotensin antagonist selective for angiotensin-(1–7): Evidence that the actions of angiotensin-(1–7) are mediated by specific angiotensin receptors
  391. Angiotensins